' fill='%23ffffff'%3E%3Cpath d='M283.94,167.31l386.39,516.64L281.5,1104h87.51l340.42-367.76L984.48,1104h297.8L874.15,558.3l361.92-390.99 h-87.51l-313.51,338.7l-253.31-338.7H283.94z M412.63,231.77h136.81l604.13,807.76h-136.81L412.63,231.77z'%3E%3C/path%3E%3C/g%3E%3C/svg%3E%0A){kind=small}
Search result
South
Name of organisation NHS Lothian Population 978K Annual outpatient visits 730K R&D Director Professor Alasdair Gray Address Usher Building, The University of Edinburgh, 5-7 Little France Road, Edinburgh BioQuarter (Gate 3), EH16 4UX Telephone 0131 242 6476 Email
Resources for Researchers
Final Health Research Authority (HRA) Clinical Trials Guidance Published
The Health Research Authority (HRA) has published final guidance to accompany the updated clinical trials regulations which come into force across all four nations of the UK (Scotland, England, Northern Ireland and Wales) on 28 April 2026 Over the last year, the HRA has engaged with a range of people and organisations, including researchers, sponsors and industry, to make sure the guidance is simple, clear and easy to follow. The guidance sets out what will change in...
About the Hepatology Specialty Group
The Hepatology Specialty Group oversees research that deals with the diagnosis and management of patients with diseases of the liver, biliary tree, and pancreas. Topics of Hepatology research include Acute and chronic liver disease including liver failure The impact of identifying, screening and treating viral hepatitis Liver fibrosis and cirrhosis Normal and abnormal liver metabolism Genetic studies including pharmacongenetics Biomark...
Edinburgh Clinical Trials Management Course 2025
National Contract Value Review
The national contract value review (NCVR) is a standardised, national approach to costing for commercial contract research From 14 October 2024, NCVR will include Early Phase (phase I and IIa) and Advanced Therapeutic Medicinal Products (ATMPs) studies. Since its introduction across the UK in 2023 it has helped speed up commercial research set up times, making the UK a more attractive place for commercial organisations to undertake research studies, ensuring UK patients have e...
Get Involved
Glasgow Clinical Research Facility (GCRF) believes in a model of integrated public engagement, patient involvement and research participation – by working together to improve healthcare through research. It is our aim to make research involvement as accessible as possible and have a wide range of patients and public/lay representatives to steer our research and support researchers to identify and conduct high-quality clinical research. Learn more about participating in res...
Patient and public involvement in mental health
Over the past decade, the role of patient and public involvement (PPI) in mental health research has grown enormously as its value to research excellence has been recognised and accepted. Over the past few years, PPI has cemented itself as both a core value of high quality clinical research and an intrinsically important part of any successful and well-regarded clinical research trial. -------------------------------------- The
Training and Events
The Network try to ensure a presence at relevant events across the country and share training opportunities of interest to the primary care research community. The Network is not responsible for the content on external pages.
Regional Working
The major research Boards across Scotland - North (NHS Grampian), East (NHS Tayside), South (NHS Lothian) and West (NHS Greater Glasgow & Clyde) - play a leading role in supporting the delivery of research and R&D Directors from these Health Boards form part of the NRS Strategy Board providing regional expertise and an in-depth view of research activity across Scotland. Together with the Chief Scientist Office (CSO) they work to develop common, simplified systems to support bot...
